Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27 - PubMed (original) (raw)

Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27

S A Rice et al. J Virol. 1990 Apr.

Abstract

Infected-cell protein 27 (ICP27) is a herpes simplex virus type 1 alpha, or immediate-early, protein involved in the regulation of viral gene expression. To better understand the function(s) of ICP27 in infected cells, we have isolated and characterized viral recombinants containing defined alterations in the ICP27 gene. The mutant virus d27-1 contains a 1.6-kilobase deletion which removes the ICP27 gene promoter and most of the coding sequences, while n59R, n263R, n406R, and n504R are mutants containing nonsense mutations which encode ICP27 molecules truncated at their carboxyl termini. All five mutants were defective for lytic replication in Vero cells. Analysis of the mutant phenotypes suggests that ICP27 has the following regulatory effects during the viral infection: (i) stimulation of expression of gamma-1 genes, (ii) induction of expression of gamma-2 genes, (iii) down regulation of expression of alpha and beta genes late in infection, and (iv) stimulation of viral DNA replication. Cells infected with the mutant n504R expressed wild-type levels of gamma-1 proteins but appeared to be unable to efficiently express gamma-2 mRNAs or proteins. This result suggests that ICP27 mediates two distinct transactivation functions, one which stimulates gamma-1 gene expression and a second one required for gamma-2 gene induction. Analysis of the mutant n406R suggested that a truncated ICP27 polypeptide can interfere with the expression of many viral beta genes. Our results demonstrate that ICP27 has a variety of positive and negative effects on the expression of viral genes during infection.

PubMed Disclaimer

Cited by

Mutations in the activation region of herpes simplex virus regulatory protein ICP27 can be trans dominant.
Smith IL, Sekulovich RE, Hardwicke MA, Sandri-Goldin RM. Smith IL, et al. J Virol. 1991 Jul;65(7):3656-66. doi: 10.1128/JVI.65.7.3656-3666.1991. J Virol. 1991. PMID: 1645788 Free PMC article.
Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses.
Kosz-Vnenchak M, Coen DM, Knipe DM. Kosz-Vnenchak M, et al. J Virol. 1990 Nov;64(11):5396-402. doi: 10.1128/JVI.64.11.5396-5402.1990. J Virol. 1990. PMID: 2170678 Free PMC article.
Identification and transcriptional analyses of the UL3 and UL4 genes of equine herpesvirus 1, homologs of the ICP27 and glycoprotein K genes of herpes simplex virus.
Zhao Y, Holden VR, Harty RN, O'Callaghan DJ. Zhao Y, et al. J Virol. 1992 Sep;66(9):5363-72. doi: 10.1128/JVI.66.9.5363-5372.1992. J Virol. 1992. PMID: 1323700 Free PMC article.
Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.
Sun A, Devi-Rao GV, Rice MK, Gary LW, Bloom DC, Sandri-Goldin RM, Ghazal P, Wagner EK. Sun A, et al. J Virol. 2004 Oct;78(19):10470-8. doi: 10.1128/JVI.78.19.10470-10478.2004. J Virol. 2004. PMID: 15367613 Free PMC article.
Host MOV10 is induced to restrict herpes simplex virus 1 lytic infection by promoting type I interferon response.
Yang X, Xiang Z, Sun Z, Ji F, Ren K, Pan D. Yang X, et al. PLoS Pathog. 2022 Feb 14;18(2):e1010301. doi: 10.1371/journal.ppat.1010301. eCollection 2022 Feb. PLoS Pathog. 2022. PMID: 35157734 Free PMC article.

References

1. J Virol. 1989 Dec;63(12):5258-67 - PubMed
1. J Virol. 1989 Aug;63(8):3399-407 - PubMed
1. J Virol. 1975 Dec;16(6):1650-68 - PubMed
1. J Virol. 1979 Jan;29(1):275-84 - PubMed
1. Virology. 1980 Feb;101(1):10-24 - PubMed

Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27 - PubMed (original) (raw)